An alternative chemotherapy to treat Chagas' disease is proposed.
HIV aspartic peptidase inhibitors (PIs) reduce the viability of Trypanosoma cruzi trypomastigotes.
HIV-PIs caused many morphological/ultrastructural alterations in trypomastigotes.
Nelfinavir and lopinavir target aspartic peptidases and proteasomes of T. cruzi.